dual agonist glp-1 glucagon The current significance and prospects for the use of receptor agonism GLP-1/Glucagon The Road towards Triple Agonists:
Description
This is the worst the GLP drugs will ever be The smartest person I know in medicine, Dave Park, has told me the only reason surgeons ever have something to do is because medicine hasnt figured out how to solve the problem yet. And in that spirit, todays newsletter is about celebrating the advances in the field of the GLP drugs, which are solving a problem I didnt think medicine would ever solve: curing obesity and metabolic syndrome in our modern food and movement environment
Individual results vary and a medical provider will determine your specific treatment plan
Exclusion criteria were: (1) reviews, commentaries, or editorials
Nevertheless, it must be acknowledged that some studies failed to report any association between T2DM and TC (Kitahara et al., 2012
